Page last updated: 2024-08-22

tiletamine hydrochloride and Medulloblastoma

tiletamine hydrochloride has been researched along with Medulloblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castro-Gamero, AM; Oliveira, HF; Pezuk, JA; Ramos, PMM; Scrideli, CA; Tone, LG; Umezawa, K	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Medulloblastoma

Article	Year
Antineoplastic Effects of NF-κB Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines. Anti-cancer agents in medicinal chemistry, 2018, Volume: 18, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Movement; Cell Proliferation; Cyclohexanones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Medulloblastoma; Molecular Structure; NF-kappa B; Structure-Activity Relationship; Tumor Cells, Cultured	2018

Article

Year

Antineoplastic Effects of NF-κB Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines.

Anti-cancer agents in medicinal chemistry, 2018, Volume: 18, Issue:4

Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Movement; Cell Proliferation; Cyclohexanones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Medulloblastoma; Molecular Structure; NF-kappa B; Structure-Activity Relationship; Tumor Cells, Cultured

2018